ClinicalTrials.Veeva

Menu

Navigating the Transition to Adulthood: A Dual Language Mobile App for Latino Youth With ASD and Their Families

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Begins enrollment in 3 months

Conditions

Autism Spectrum Disorder (ASD)

Treatments

Behavioral: ¡Iniciando! mHealth App

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07170163
HSC-MS-25-0519
1R03HD119485 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to determine useability and satisfaction characteristics,product usage data,methodological feasibility parameters and feasibility metrics of the mHealth app adapted intervention on the mental health, quality of life, and adaptive functioning of Latino transition aged young adults with ASD and their parents.

Enrollment

30 estimated patients

Sex

All

Ages

18 to 25 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Latino young adults with ASD ASD with a score of 15 or greater on the Social Communication Questionnaire-Lifetime (SCQ-L)
  • meets Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), criteria for ASD based on a DSM-5-TR ASD symptom checklist
  • previous diagnosis of ASD from a licensed mental health or medical professional(f they have not been diagnosed by a licensed mental health or medical professional, a complete a diagnostic evaluation will be conducted, using semi-structured interviews, questionnaires, the autism diagnostic interview-revised (ADI-R), and the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) to confirm ASD diagnosis)
  • above the "moderate" cut off for symptoms of anxiety or depression( Depression and anxiety symptoms will be assessed via the Patient Health Questionnaire-9 (PHQ-9) and the Generalized Anxiety Disorder-7 (GAD-7)
  • Spanish-speaking parents

Exclusion criteria

  • low intelligence quotient (IQ) score (Verbal IQ < 70) on the verbal IQ on Kaufman Brief Intelligence Test Second Edition (KBIT-2)
  • psychotic as determined by the Structured clinical interview for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM5): Research Version (SCID-5-RV), or are actively suicidal with an active plan.
  • substance abuse

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

¡Iniciando! mHealth App
Experimental group
Treatment:
Behavioral: ¡Iniciando! mHealth App

Trial contacts and locations

1

Loading...

Central trial contact

Antonio Pagán, PhD; Ronald Acierno, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems